Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07568639Not ApplicableNot Yet Recruiting

Multi-Site Cortical Puncture for DOR

Role: collaborator

NCT06481410Not ApplicableRecruiting

Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic Shock

Role: collaborator

NCT04681651Phase 2Completed

Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)

Role: collaborator

NCT05605145Unknown

PCP in Immunocompromised Population in Southern China

Role: collaborator

All 4 trials loaded